Print Digg

Article

Turmeric: The Miracle Spice

Friday, June 23, 2017


Today‚Äôs Friday Pearl addresses curcumin, the active ingredient in turmeric root (Curcuma longa) and the ever-growing scientific information now suggesting multitargeted therapy may prove to be better than monotargeted prescription drug therapy for a number of health problems.

Curcumin has been used in India as a spice, as a food preservative, and for health care for centuries. It has been clinically suggested to exhibit antioxidant, anti-inflammatory, antiviral, antifungal and antibacterial activities associated with a number of structure / function health issues.

Curcumin and the aging retina

An original research study published in Drug Design, Development and Therapy looked at the effect of curcumin on aging retinal pigment epithelial cells.

The investigators reported that in the aging state, curcumin significantly improved cell viability by regulating oxidative stress, apoptosis, and decreasing intracellular reactive oxygen species (ROS) when compared with the control group.

Other studies suggest that curcumin may be an efficient vascular endothelial growth factor (VGEF) blocker similar to the drugs now being injected into the eye.

This information may prove to be particularly important to protect against changes associated with age-related eye health.

Curcumin consumption: blood lipids and glucose levels

A study published in the April 2016 Nutrition Research Practice used data obtained from the Korean National Health and Nutrition Examination Survey to assess curry consumption frequency as well as blood glucose and blood lipid levels.  

Most curries include a moderate amount of curcumin, or turmeric, spice.

The blood glucose and triglyceride levels were significantly lower in the moderate curry consumption group compared to the low curry consumption group.


Ellen Troyer, with Spencer Thornton, MD, and the Biosyntrx staff

 

PEARL

Because curcumin is poorly absorbed, we always recommend looking for curcumin that includes a minimum of 20 percent curcuminoids.








Crestpoint Management, LTD instrument announcement:
Hydrodissection Cannula M3919

Bibliography

Clinical references available in the Biosyntrx office.